Medtronic (MDT) Cash from Operations (2014 - 2026)

Medtronic (MDT) has 13 years of Cash from Operations data on file, last reported at 2573000000.0 in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations rose 1.78% year-over-year to 2573000000.0; the trailing twelve-month figure through Apr 2026 stood at 7330000000.0 (up 4.06% YoY), and the FY2026 full-year result was 7330000000.0, up 4.06% from the prior year.
• Cash from Operations retreated to 2573000000.0 in Q2 2026, from 2744000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 2777000000.0 in Q2 2024 to a low of 661000000.0 in Q4 2023.
• A 5-year average of 1749166666.67 and a median of 1815500000.0 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations sank 47.88% in 2022 and soared 57.18% in 2024, its largest moves.
• Tracing MDT's Cash from Operations over 5 years: stood at 922000000.0 in 2022, then declined by 28.31% to 661000000.0 in 2023, then soared by 44.93% to 958000000.0 in 2024, then fell by 3.44% to 925000000.0 in 2025, then jumped by 178.16% to 2573000000.0 in 2026.
• Business Quant data shows MDT's Cash from Operations at 2573000000.0 in Q2 2026, 2744000000.0 in Q1 2026, and 925000000.0 in Q4 2025.